Cargando…
Prognostic value of γ‐glutamyltransferase‐to‐albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery
Pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy with poor prognosis. Many preoperative biomarkers can predict postoperative survival of PDAC patients. In this study, we created a novel ratio index based on preoperative liver function test, γ‐glutamyltransferase‐to‐albumin ratio (...
Autores principales: | Li, Shuo, Xu, Huaxiang, Wu, Chuntao, Wang, Wenquan, Jin, Wei, Gao, Heli, Li, Hao, Zhang, Shirong, Xu, Jinzhi, Zhang, Wuhu, Xu, Shuaishuai, Li, Tianjiao, Ni, Quanxing, Yu, Xianjun, Liu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382708/ https://www.ncbi.nlm.nih.gov/pubmed/30632317 http://dx.doi.org/10.1002/cam4.1957 |
Ejemplares similares
-
The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma
por: Li, Shuo, et al.
Publicado: (2019) -
Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
por: Li, Tianjiao, et al.
Publicado: (2019) -
The role of collagen in cancer: from bench to bedside
por: Xu, Shuaishuai, et al.
Publicado: (2019) -
Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21
por: Lin, Xuan, et al.
Publicado: (2021) -
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer
por: Ye, Longyun, et al.
Publicado: (2022)